Kamada: Kedrion Deal Locks In Growth (NASDAQ:KMDA)

Female nurse holding blood collection tubes

FluxFactory/E+ via Getty Images

I recently wrote an article outlining the investment case for Kamada Ltd. (NASDAQ:KMDA), a small manufacturer of plasma-based pharmaceuticals. This is an unexpectedly quick update following Kamada’s announcement of a major commercial agreement.

As explained in

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *